Temelimab: Early clinical trial suggests potential for remyelination
An update about the latest MS research
Temelimab: Early clinical trial suggests potential for remyelination Read More »
Research
The team are recruiting 200 people with advanced progressive MS
Source MS Society: Last year, we announced a new trial testing if a drug called cladribine can slow down the worsening of arm and hand movement for people with advanced primary or secondary progressive MS.
The team are recruiting 200 people with advanced progressive MS Read More »
Participants wanted for research on the narratives of people with multiple sclerosis following a mindfulness programme.
Request from Abbie Turner, Trainee Clinical Psychologist, Exeter University
Machine learning identifies new subtypes of MS from MRI scans
Source MS Trust: Researchers wanted to find out if there are hidden patterns in MRI brain scans taken over time that would better identify biological differences in MS activity and detect progression earlier.
Machine learning identifies new subtypes of MS from MRI scans Read More »
Introducing Octopus – the world’s first multi-arm, multi-stage trial for MS
Source MS Society: We’re pleased to introduce Octopus – our revolutionary, multi-arm, multi-stage trial that will transform the way we test treatments for progressive MS.
Introducing Octopus – the world’s first multi-arm, multi-stage trial for MS Read More »
Ofatumumab licensed for active relapsing-remitting MS in UK
Source MS Society: The Medicines and Healthcare products Regulatory Agency (MHRA), and European Commission (EC) have licenced ofatumumab to treat adults with active relapsing MS.
Ofatumumab licensed for active relapsing-remitting MS in UK Read More »
UK to test existing drugs as treatment for MS in world-first trial
Source The Guardian: Researchers will test several drugs at once to speed up identification of those that slow or reverse symptoms
UK to test existing drugs as treatment for MS in world-first trial Read More »
Why do our brains stop repairing myelin as we get older?
Source MS Society: A new study has discovered a specific gene plays a major role in myelin repair becoming less effective as we age. To stop MS from getting worse, we need to find ways to repair damaged myelin – the protective coating around nerves in our brains. Although our bodies have the natural ability to repair myelin,
Why do our brains stop repairing myelin as we get older? Read More »
Mindfulness-based interventions for mental well-being among people with MS
An interesting study on mindfulness-based interventions for mental well-being among people with multiple sclerosis.
Mindfulness-based interventions for mental well-being among people with MS Read More »